Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Home / H. Lee Moffitt Cancer Center and Research Institute, Inc.
Last updated: April 19, 2026

H. Lee Moffitt Cancer Center and Research Institute, Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17272738 USE OF DELTA-TOCOTRIENOL FOR TREATING CANCER CHICKS, ASHLI ARIANA 1626 Final Rejection Mar 02, 2021
16330810 ENDOTRACHEAL TUBE STYLET DITMER, KATHRYN ELIZABETH 3785 Final Rejection Mar 06, 2019

Managing H. Lee Moffitt Cancer Center and Research Institute, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month